UCB and Biogen say their first phase 3 trial of their systemic lupus erythematosus (SLE) candidate dapirolizumab pegol was a success, and a second is now expected to start before the end of the year.

MSD and Daiichi Sankyo have revealed some of the clinical data that prompted them to start pivotal testing of ifinatamab deruxtecan (I-DXd) in patients with previously treated, extensive-stage small ...

Here are some hints to help you win NYT Connections #998.

Looking for today's NYT Connections hints? Some help and the answers for today's game are right here to help keep your streak alive.

Erasable electric fields written by laser light onto crystal surfaces can trap, align, and release living cells without ...

What's CODE SWITCH? It's the fearless conversations about race that you've been waiting for. Hosted by journalists of color, our podcast tackles the subject of race with empathy and humor. We explore ...

Abstract: In this article (Part I), a study of the zero-sequence stray losses in wye-wye-connected transformers without a (stabilizing) tertiary winding is presented. The paper shows where and when ...

Abstract: This article presents a multiport power electronic transformer (PET) based on a three-phase four-arm full-bridge modular multilevel converter (MMC), which is suitable for the hybrid ac–dc ...